医源性尿道直肠瘘治疗和预后的研究进展  

Advance in research of treatment and prognosis of iatrogenic rectourethral fistula

作　　者：吴自强 薛睿智 唐正严[1,2] WU Ziqiang;XUE Ruizhi;TANG Zhengyan(Department of Urology,Xiangya Hospital,Central South University,Changsha 410008;Hunan Engineering Laboratory for Diagnosis and Treatment Technology of Urogenital Diseases,Changsha 410008,China)

机构地区：[1]中南大学湘雅医院泌尿外科,长沙410008 [2]泌尿生殖系统疾病诊疗技术湖南省工程实验室,长沙410008

出　　处：《中南大学学报（医学版）》2021年第7期753-758,共6页Journal of Central South University ：Medical Science

基　　金：湖南省卫生健康委科研计划(B2019185)。

摘　　要：尿道直肠瘘(rectourethral fistula,RUF)是一种主要发生在前列腺癌治疗过程中的严重并发症,由于其解剖位置特殊,病情复杂,预后往往因人而异,成为泌尿外科最棘手的疾病之一。目前对于RUF的治疗主要有使用抗生素和留置导尿管等保守治疗及经会阴路径、括约肌路径、肛门路径、腹路径等手术治疗方法。具体选取哪种方式治疗RUF尚无明确定论,且近年来RUF的病因发生了较大变化。总结不同治疗方式的优缺点及其预后,将为RUF的治疗决策提供重要参考依据。Recturethral fistula(RUF)is a kind of serious complication that mainly happened during the treatment of prostate cancer.It has become one of the most difficult diseases to treat in urology because of its special anatomical location,complicated condition,and the varied prognosis.At present,the main treatment methods for RUF are conservative treatment such as application of antibiotics and indwelling catheters,etc.and surgical treatment such as transperineal approach,transsphincter approach,transanal approach,transabdominal approach,etc.However,there is no explicit treatment protocol for RUF.What’s more,the etiology of RUF has changed greatly in recent years.Summarizing the advantages and disadvantages of different RUF’s treatment methods and their prognosis will be helpful for the decision of clinical treatment.

关 键 词：尿道直肠瘘 治疗 预后 前列腺癌 

分 类 号：R737.25[医药卫生—肿瘤]